Mark Bishton, MBChB, MRCP, FRCPath, PhD, Nottingham University Hospitals NHS Foundation Trust, Nottingham, UK, shares some insights into a study evaluating the real-world safety and efficacy of CT-P10 in patients with diffuse large B-cell lymphoma (DLBCL). This interview took place at the 63rd Annual Scientific Meeting of the British Society for Haematology (BSH) 2023, held in Birmingham, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.